Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Younger generations understand nuclear weapons through digital screens rather than personal experience. The future of nuclear risk reduction hinges on the ability to communicate with and engage young people directly; to educate and mobilize them around nuclear issues.
Sign up for our newsletter to get the latest on nuclear and biological threats.
As protein design tools and other biological AI models become more capable of designing novel biological components and systems, the mechanisms to prevent misuse have not kept pace.
Multisectoral collaboration is a fundamental requirement for stronger health security.
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
The convergence of artificial intelligence and the life sciences continues to accelerate. The AIxBio Horizon Scan: Spring 2026 shows that while individual advances may seem incremental, their combined trajectory is significant. Progress is outpacing governance frameworks.
Some of the world’s largest AI companies—Google DeepMind, OpenAI, and Anthropic—have warned that their models could be misused to cause harm with biology. The India AI Impact Summit is a critical moment for policymakers, scientists, developers, and biosecurity experts to work together on responsible governance that reduces AIxBio risks.
The AI-biology convergence offers enormous benefits but also brings about risks as we’ve never seen before. Without action from multiple disciplines, the race for AI development and dominance could become a race to the bottom when it comes to safety and security.
Innovation requires security, and security requires innovation. Congress needs to act decisively to ensure U.S. leadership in biotechnology is paired with governance that keeps its development secure.
As the capabilities of biological AI tools continue to advance at an accelerating pace, it is vital that DNA synthesis providers and others in the biosecurity space embrace new guardrails to prevent their misuse.
Over the past decade, governments, private industry, and academic institutions have increased their investments in bioscience research and development, yielding global benefits. However, these advancements have also increased the risk of deliberate misuse of biology to cause harm.
OpenAI's latest release, ChatGPT Agent, represents a significant leap forward in artificial intelligence capabilities—and with it comes a thoughtful, proactive approach to managing the biosecurity risks that advanced AI systems can pose.
Senior Director, Communications
Director, Communications
Sign up for regular updates on innovative, real-world solutions to existential threats.
